Close Menu

NEW YORK (GenomeWeb) – A team led by researchers at the Karolinska Institute in Sweden has analyzed the proteomic landscape of breast cancer tumors, finding similar subclasses as transcriptome-based analyses but also additional ones.

Breast tumors can be divvied into five subtypes — basal-like, normal-like, HER2, luminal A, and luminal B — based on their expression of 50 transcripts, known as the PAM50, but the researchers, led by the Karolinska Institute's Janne Lehtiö, noted that many patients are still misclassified.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Feb
25
Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Feb
27
Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.